Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2022

Aug 4, 2022

284_dirs_2022-08-04_ef9ffe0a-3f64-4300-8b8f-f2f512b54f1e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2022-08-03

Reporting Person: Guindo Chirfi (Chief Marketing Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-08-03 Restricted Stock Unit $ A 110705 Acquired 2025-08-03 Common Stock (110705) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2.7 Direct
Common Stock-401(k) Plan 51.1609 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025.